DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Israel
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
REKA logo

Rekah Pharmaceutical Industry Ltd. Stock Price

TASE:REKA Community·₪122.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

REKA Share Price Performance

₪0
-11.60 (-100.00%)
​
₪0
-11.60 (-100.00%)
​
Price ₪0
Thu, 10 Sep 26
Share Pricen/a

REKA Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet and good value.

2 Risks
1 Reward
View Full Analysis

Rekah Pharmaceutical Industry Ltd. Key Details

₪304.0m

Revenue

₪235.4m

Cost of Revenue

₪68.6m

Gross Profit

₪84.4m

Other Expenses

-₪15.8m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
-1.39
22.57%
-5.20%
60.6%
View Full Analysis

About REKA

Founded
1947
Employees
390
CEO
Mordechai Elgrabli
WebsiteView website
www.rekah.co.il

Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel. The company offers steroids, antibiotics, and ophthalmic products, as well as dermo-cosmetics products. Its portfolio of products comprise Rx and OTC drugs, and medical devices used in various therapeutic fields, such as urinary tract pain, steroid anti-inflammatories, cough, expectoration and bronchitis, motion sickness, runny nose and congestion, skin disinfection, wounds, burns and insect bites, eye infections, glaucoma, dryness, allergies, fever and pain relief, mouth, depression and anxiety, muscle and joint pain, antibiotics, fungal infections, anemia and nutritional deficits, ear pain, babies and children, etc. The company was founded in 1947 and is based in Holon, Israel.

Recent REKA News & Updates

Recent updates

No updates

Rekah Pharmaceutical Industry Ltd. Competitors

BONS logo

Bonus BioGroup

Symbol: TASE:BONS
Market cap: ₪206.8m
INCR logo

InterCure

Symbol: TASE:INCR
Market cap: ₪193.9m
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide